Hypoglycaemia risk increases when GLP-1 medications are combined with insulin or sulfonylureas, with sweating being a classic warning sign requiring blood glucose monitoring
BarnhartASAnthonyALConawayKRSibbittBGDelaneyEHaluschakJet al
Industry analysts, including GlobalData, predict FDA approval for retatrutide in 2027, with a projected sales forecast of $15.6 billion by 2031
Because it is naturally occurring in our cells, it is generally very well-tolerated, making it an excellent partner for more intense ingredients like retinol
This eliminates confounding from intensive lifestyle enrichment (STEP 3, SURMOUNT-3) and run-in/maintenance designs (STEP 4, SURMOUNT-4) that inflate active-arm weight loss estimates
Mar 30, 2026 5 min read Anti-Aging How Does AOD-9604 Peptide Work in Lipolysis and Metabolic Studies